These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18368206)

  • 1. Towards elimination: measles susceptibility in Australia and 17 European countries.
    Andrews N; Tischer A; Siedler A; Pebody RG; Barbara C; Cotter S; Duks A; Gacheva N; Bohumir K; Johansen K; Mossong J; Ory Fd; Prosenc K; Sláciková M; Theeten H; Zarvou M; Pistol A; Bartha K; Cohen D; Backhouse J; Griskevicius A
    Bull World Health Organ; 2008 Mar; 86(3):197-204. PubMed ID: 18368206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The seroepidemiology of measles in Western Europe.
    de Melker H; Pebody RG; Edmunds WJ; Lévy-Bruhl D; Valle M; Rota MC; Salmaso S; van den Hof S; Berbers G; Saliou P; Spaendonck MCV ; Crovari P; Davidkin I; Gabutti G; Hesketh L; Morgan-Capner P; Plesner AM; Raux M; Tische A; Miller E
    Epidemiol Infect; 2001 Apr; 126(2):249-59. PubMed ID: 11349976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.
    Nardone A; Tischer A; Andrews N; Backhouse J; Theeten H; Gatcheva N; Zarvou M; Kriz B; Pebody RG; Bartha K; O'Flanagan D; Cohen D; Duks A; Griskevicius A; Mossong J; Barbara C; Pistol A; Slaciková M; Prosenc K; Johansen K; Miller E
    Bull World Health Organ; 2008 Feb; 86(2):118-25. PubMed ID: 18297166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the Population Susceptibility Against Measles in Slovakia.
    Zibolenová J; Chladná Z; Švihrová V; Baška T; Waczulíková I; Hudečková H
    Cent Eur J Public Health; 2017 Mar; 25(1):46-54. PubMed ID: 28399355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles control in Australia - threats, opportunities and future needs.
    MacIntyre CR; Kpozehouen E; Kunasekaran M; Harriman K; Conaty S; Rosewell A; Druce J; Martin N; Heywood AE; Gidding HF; Wood J; Nicholl S
    Vaccine; 2018 Jul; 36(30):4393-4398. PubMed ID: 29934234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination.
    Funk S; Knapp JK; Lebo E; Reef SE; Dabbagh AJ; Kretsinger K; Jit M; Edmunds WJ; Strebel PM
    BMC Med; 2019 Sep; 17(1):180. PubMed ID: 31551070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    Smetana J; Chlibek R; Hanovcova I; Sosovickova R; Smetanova L; Gal P; Dite P
    PLoS One; 2017; 12(1):e0170257. PubMed ID: 28085960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents].
    Poethko-Müller C; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1243-52. PubMed ID: 23990086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of epidemiological studies for progress of measles elimination].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles elimination in the Americas: a comparison between countries with a one-dose and two-dose routine vaccination schedule.
    Sever AE; Rainey JJ; Zell ER; Hennessey K; Uzicanin A; Castillo-Solórzano C; Dietz V
    J Infect Dis; 2011 Sep; 204 Suppl 2():S748-55. PubMed ID: 21954277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C; Mankertz A
    Vaccine; 2011 Oct; 29(45):7949-59. PubMed ID: 21872633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of endemic measles transmission in Australia.
    Heywood AE; Gidding HF; Riddell MA; McIntyre PB; MacIntyre CR; Kelly HA
    Bull World Health Organ; 2009 Jan; 87(1):64-71. PubMed ID: 19197406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges to Achieving Measles Elimination, Georgia, 2013-2018.
    Khetsuriani N; Sanadze K; Chlikadze R; Chitadze N; Dolakidze T; Komakhidze T; Jabidze L; Huseynov S; Ben Mamou M; Muller C; Zakhashvili K; Hübschen JM
    Emerg Infect Dis; 2020 Nov; 26(11):2565-2577. PubMed ID: 33079037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of Australia's measles control programme over the past decade.
    Gidding HF
    Epidemiol Infect; 2005 Feb; 133(1):99-105. PubMed ID: 15724716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to measles in the Croatian population.
    Borcić B; Mazuran R; Kaić B
    Eur J Epidemiol; 2003; 18(11):1079-83. PubMed ID: 14620943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.